3644 results for «2742»
3644 results
TAVI procedural complications - Part 1: VSD, valve embolisation, and more
19 May 2026 – From EuroPCR 2026
This session focuses on the complex complications that can arise during TAVI procedures, such as ventricular septal defects, valve embolisation, and other critical events. Through detailed case analyses, it offers strategies for recognition, prevention, and management to improve patient safety and outcomes.
AI fundamentals for busy cardiologists: opportunities, limitations and safe use
19 May 2026 – From EuroPCR 2026
Designed for busy cardiologists, this session elucidates the fundamentals of artificial intelligence relevant to cardiology practice. It covers the main AI tool families, including large language models and computer vision, and emphasizes effective and safe prompting techniques for clinical and academic use. Attendees will also learn...
Structural and valvular innovations
19 May 2026 – From EuroPCR 2026
This session highlights the latest innovations in structural and valvular cardiology, featuring novel technologies such as a new self-expandable transcatheter aortic valve for aortic stenosis treatment and a temporary atrioventricular sequential pacing system. It also discusses non-clinical testing methodologies supporting U.S. market approvals, non-invasive ultrasound therapy...
How to prevent and manage complex and complicated LAA closure cases?
19 May 2026 – From EuroPCR 2026
Designed to enhance procedural success in transcatheter left atrial appendage closure, this session addresses identification of complex anatomies, management of intraprocedural challenges, and strategies to prevent and handle complications, illustrated by practical case examples and expert evaluations.
How should I treat a patient with a calcified mitral anatomy?
19 May 2026 – From EuroPCR 2026
This session explores the management of patients with calcified mitral anatomy, from advanced imaging assessment to intervention planning. It evaluates the suitability of mitral annular calcification for transcatheter edge-to-edge repair (TEER) and discusses alternative therapeutic options for patients ineligible for TEER.
Angiography-based physiology in clinical practice
19 May 2026 – From EuroPCR 2026
Investigate the clinical application of angiography-based physiology in coronary artery disease management. This session covers quantitative flow ratio (QFR) guided PCI strategies, risk stratification in chronic coronary syndrome, and prognostic value of angiography-derived indices, offering a wire-free diagnostic approach supported by recent trial data.
Innovations in vascular therapies
19 May 2026 – From EuroPCR 2026
Discover cutting-edge innovations in vascular therapies highlighting novel technologies such as Pulse Intravascular Lithotripsy (IVL) for calcium modification and Amplitude Vascular Systems. The session also presents drug-free restenosis control strategies via CD31 camouflage coating promoting physiological-grade healing, emphasizing emerging solutions aimed at improving vascular intervention outcomes.
Optimal management of primary PCI complications
19 May 2026 – From EuroPCR 2026
This session delves into the optimal management of complications arising during primary PCI. It addresses critical scenarios from initial hesitation and unexpected challenges to confident treatment strategies for vessel complications. Notably, it explores complex cases such as paradoxical embolisation following rescue PCI in STEMI patients, providing...
Aortic paravalvular leak unmasked: different faces, different strategies
19 May 2026 – From EuroPCR 2026
Examine diverse clinical scenarios and management strategies for aortic paravalvular leaks (PVL), including complex percutaneous closures post-TAVI and surgical interventions. This session presents challenging cases demonstrating varied presentations and approaches such as mechanical valve loop utilization, highlighting the complexities and tailored solutions required for successful PVL...
Risk stratification and drug therapies in coronary arteries interventions
19 May 2026 – From EuroPCR 2026
This session offers a detailed examination of risk stratification and pharmacologic therapies in coronary artery interventions. It features innovative markers such as left ventricle filling pressure (E/E' ratio) for predicting myocardial injury, clinical outcome impacts in dialysis-dependent patients, intraoperative DOAC removal during CABG, and machine learning...
Imaging-driven decision making in PCI for calcified lesions
19 May 2026 – From EuroPCR 2026
Focus on imaging-guided decision making in PCI for heavily calcified coronary lesions. This session includes case studies illustrating advanced techniques to navigate and treat challenging calcific anatomies, emphasizing the role of imaging modalities and atherectomy devices to optimize procedural success in complex settings such as left...
High-risk PCI: how to optimise the result
19 May 2026 – From EuroPCR 2026
Focused on high-risk PCI, this session presents strategies to optimize procedural outcomes in complex cases. Discussions include contemporary approaches to challenging coronary anatomy, the role of balloon aortic valvuloplasty as a bridge to Impella-supported interventions, advanced mechanical support and thrombectomy in cardiogenic shock related to left...
TAVI procedural complications - Part 2: devices issues, access-related complications and more
19 May 2026 – From EuroPCR 2026
Delve into procedural challenges encountered during TAVI, focusing on device-related issues, access complications, and bailout strategies. This session reviews real-world cases such as balloon retention, valve expansion failure, TAV-in-TAV interventions, and transcaval access lessons, providing critical insights to manage and mitigate procedural complications effectively.
Value of imaging for treatment of calcified lesions
19 May 2026 – From EuroPCR 2026
This session highlights the critical value of imaging in the treatment of calcified coronary lesions. It reviews techniques for lesion modification, including innovative balloon-based strategies and multimodality approaches for balloon-uncrossable calcified left main bifurcations. The session also discusses the tactical cracking of calcified plaques and strategies...
When the anterior leaflet gets in the way: mitral leaflet modification before TMVR
19 May 2026 – From EuroPCR 2026
This session addresses the intricacies of mitral leaflet modification techniques prior to transcatheter mitral valve replacement (TMVR). It features innovative approaches such as LAMPOON-assisted valve-in-ring replacement, balloon-assisted leaflet translocation, and strategies to overcome the challenges posed by mitral annular calcification.
Atypical STEMI presentations
20 May 2026 – From EuroPCR 2026
Investigate atypical presentations of STEMI and the unique challenges they pose in clinical management. This session covers case studies including high bleeding risk patients, mechanical complications post-surgery, spontaneous coronary artery dissection, and recurrent events, emphasizing tailored therapeutic approaches.
Typical chest pain: atypical angiogram
20 May 2026 – From EuroPCR 2026
This session addresses the management challenges posed by acute coronary syndromes when angiographic findings are ambiguous or atypical. It highlights the role of intravascular imaging in clarifying diagnoses and discusses recent insights from clinical cases and key studies such as DISCO and the latest NSTEMI EuroIntervention...
TTVR: novel techniques and new horizons
20 May 2026 – From EuroPCR 2026
Explore novel techniques and emerging technologies in transcatheter tricuspid valve replacement (TTVR). This session showcases innovative devices and approaches, early clinical experiences, and strategies to address challenges such as pacemaker leads and failed tricuspid TEER procedures.
Registries and trials in TMVR
20 May 2026 – From EuroPCR 2026
This session provides an in-depth review of registries and clinical trials focused on transcatheter mitral valve replacement (TMVR). It presents data on annular and ventricular remodeling with the HighLife system, mid- to long-term valve performance, and innovations in transseptal TMVR using novel bioprostheses.
Mitral valve-in-valve, valve-in-ring, valve-in-mac: the good, the bad and the ugly
20 May 2026 – From EuroPCR 2026
This session delves into the complexities of mitral valve interventions, focusing on valve-in-valve, valve-in-ring, and valve-in-mitral annular calcification (MAC) procedures. It addresses troubleshooting in high-risk valve-in-MAC cases, urgent transcatheter mitral valve implantation supported by microaxial flow pumps, challenges in delivering balloon expandable valves transeptally, and innovative...